Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh

Vaccine

Volumn 35, Issue 50, 2017, Pages 6967-6976

  Rolfes, Melissa A ^a   Goswami, Doli ^b   Sharmeen, Amina Tahia ^b   Yeasmin, Sultana ^b   Parvin, Nasrin ^b   Nahar, Kamrun ^b   Rahman, Mustafizur ^b   Barends, Marion ^b   Ahmed, Dilruba ^b   Rahman, Mohammed Ziaur ^b   Bresee, Joseph ^a   Luby, Stephen ^c   Moulton, Lawrence H ^d   Santosham, Mathuram ^d   Fry, Alicia M ^a   Brooks, W Abdullah ^b,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Children; Clinical trial; Influenza; Vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; POLIOMYELITIS VACCINE;

AGE; ARTICLE; BANGLADESH; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEVER; HUMAN; INCIDENCE; INFLUENZA; LABORATORY TEST; MAJOR CLINICAL STUDY; NASOPHARYNX; NONHUMAN; PARALLEL DESIGN; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX; SIDE EFFECT; FEMALE; IMMUNOLOGY; INFANT; MALE; TREATMENT OUTCOME;

BANGLADESH; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; TREATMENT OUTCOME;

EID: 85033673400     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.10.074     Document Type: Article

References (30)

1. Nair, H., Brooks, W.A., Katz, M., Roca, A., Berkley, J.A., Madhi, S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378 (2011), 1917–1930.
2. Lafond, K.E., Nair, H., Rasooly, M.H., Valente, F., Booy, R., Rahman, M., et al. Global role and burden of influenza in pediatric respiratory hospitalizations, 1982–2012: a systematic analysis. PLoS Med, 13, 2016, e1001977.
3. World Health Organization, Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 87 (2012), 461–476.
4. Hoberman, A., Greenberg, D.P., Paradise, J.L., Rockette, H.E., Lave, J.R., Kearney, D.H., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 290 (2003), 1608–1616.
5. Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., Schmitt, H.J., et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 365 (2011), 1406–1416.
6. Madhi, S.A., Dittmer, S., Kuwanda, L., Venter, M., Cassim, H., Lazarus, E., et al. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS 27 (2013), 369–379.
7. Brooks, W.A., Santosham, M., Naheed, A., Goswami, D., Wahed, M.A., Diener-West, M., et al. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet 366 (2005), 999–1004.
8. Brooks, W.A., Breiman, R.F., Goswami, D., Hossain, A., Alam, K., Saha, S.K., et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 77 (2007), 795–801.
9. Brooks, W.A., Goswami, D., Rahman, M., Nahar, K., Fry, A.M., Balish, A., et al. Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis J 29 (2010), 216–221.
10. Zaman, R.U., Alamgir, A.S., Rahman, M., Azziz-Baumgartner, E., Gurley, E.S., Sharker, M.A., et al. Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007–2008. PLoS One, 4, 2009, e8452.
11. Saha, S., Chadha, M., Al Mamun, A., Rahman, M., Sturm-Ramirez, K., Chittaganpitch, M., et al. Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia. Bull World Health Organ 92 (2014), 318–330.
12. Brooks, W.A., Zaman, K., Lewis, K.D., Ortiz, J.R., Goswami, D., Feser, J., et al. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health 4 (2016), e946–e954.
13. World Health Organization. CDC protocol of realtime RTPCR for influenza A(H1N1); 2009.
14. World Health Organization. WHO manual on animal influenza detection and surveillance; 2002.
15. Blyth, C.C., Jacoby, P., Effler, P.V., Kelly, H., Smith, D.W., Robins, C., et al. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics 133 (2014), e1218–e1225.
16. Eisenberg, K.W., Szilagyi, P.G., Fairbrother, G., Griffin, M.R., Staat, M., Shone, L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003–2004 and 2004–2005 influenza seasons. Pediatrics 122 (2008), 911–919.
17. Heinonen, S., Silvennoinen, H., Lehtinen, P., Vainionpaa, R., Ziegler, T., Heikkinen, T., Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 11 (2011), 23–29.
18. Kelly, H., Jacoby, P., Dixon, G.A., Carcione, D., Williams, S., Moore, H.C., et al. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J 30 (2011), 107–111.
19. Ritzwoller, D.P., Bridges, C.B., Shetterly, S., Yamasaki, K., Kolczak, M., France, E.K., Effectiveness of the 2003–2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 116 (2005), 153–159.
20. Shuler, C.M., Iwamoto, M., Bridges, C.B., Marin, M., Neeman, R., Gargiullo, P., et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003–2004. Pediatrics 119 (2007), e587–e595.
21. Szilagyi, P.G., Fairbrother, G., Griffin, M.R., Hornung, R.W., Donauer, S., Morrow, A., et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 162 (2008), 943–951.
22. Treanor, J.J., Talbot, H.K., Ohmit, S.E., Coleman, L.A., Thompson, M.G., Cheng, P.Y., et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 55 (2012), 951–959.
23. Halasa, N.B., Gerber, M.A., Berry, A.A., Anderson, E.L., Winokur, P., Keyserling, H., et al. Safety and immunogenicity of full-dose trivalent inactivated influenza vaccine (TIV) compared with half-dose TIV administered to children 6 through 35 months of age. J Pediatr Infect Dis Soc 4 (2015), 214–224.
24. Mugitani, A., Ito, K., Irie, S., Eto, T., Ishibashi, M., Ohfuji, S., et al. Immunogenicity of the trivalent inactivated influenza vaccine in young children less than 4 years of age, with a focus on age and baseline antibodies. Clin Vaccine Immunol 21 (2014), 1253–1260.
25. Pavia-Ruz, N., Angel Rodriguez Weber, M., Lau, Y.L., Nelson, E.A., Kerdpanich, A., Huang, L.M., et al. A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age. Hum Vaccin Immunother 9 (2013), 1978–1988.
26. Walter, E.B., Neuzil, K.M., Zhu, Y., Fairchok, M.P., Gagliano, M.E., Monto, A.S., et al. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?. Pediatrics 118 (2006), e570–e578.
27. Wang, L., Chandrasekaran, V., Domachowske, J.B., Li, P., Innis, B.L., Jain, V.K., Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in US children 6–35 months of age during 2013–2014: results from a phase II randomized trial. J Pediatr Infect Dis Soc 5 (2016), 170–179.
28. Walter, E.B., Rajagopal, S., Zhu, Y., Neuzil, K.M., Fairchok, M.P., Englund, J.A., Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?. Vaccine 28 (2010), 4376–4383.
29. Skowronski, D.M., Hottes, T.S., Chong, M., De Serres, G., Scheifele, D.W., Ward, B.J., et al. Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics 128 (2011), e276–e289.
30. Thompson, M.G., Clippard, J., Petrie, J.G., Jackson, M.L., McLean, H.Q., Gaglani, M., et al. Influenza vaccine effectiveness for fully and partially vaccinated children 6 months to 8 years old during 2011–2012 and 2012–2013: the importance of two priming doses. Pediatr Infect Dis J 35 (2016), 299–308.